Cleared Traditional

K031417 - ILT SAFE CROSS 0.035 SUPPORT CATHETER

K031417 is an FDA 510(k) clearance for ILT SAFE CROSS 0.035 SUPPORT CATHETER, manufactured by Intra Luminal Therapeutics, Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 67-day FDA review.

K031417 · Intra Luminal Therapeutics, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2003
Decision
67d
Days
Class 2
Risk

K031417 is an FDA 510(k) clearance for the ILT SAFE CROSS 0.035 SUPPORT CATHETER, MODEL C135SN1. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Intra Luminal Therapeutics, Inc. (Carlsbad, US). The FDA issued a Cleared decision on July 11, 2003 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Intra Luminal Therapeutics, Inc. devices

FDA 510(k) Submission Details - K031417

510(k) Number K031417 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 05, 2003
Decision Date July 11, 2003
Days to Decision 67 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 125d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 651
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K031417.
MEDTRONIOC 7F LAUNCHER BIOPSY GUIDE CATHETER, MODEL LA7RVBB, MEDTRONIC 8F LAUNCHER BIOPSY CATHETER, MODEL LA8RVBB
K030671 · Medtronic Vascular · Jul 2003
RAPIDO CUT-AWAY CUTTER
K031459 · Guidant Corp. · Jul 2003
ATTAIN PREVAIL STEERABLE CATHETER SET, MODEL 6228CTH
K031211 · Medtronic Vascular · Jul 2003
ATB ALL-TERRAIN BALLOON PTA DILATATION CATHETER
K031766 · Cook, Inc. · Jun 2003
MODIFICATION TO NUMED TYSHAK II AND Z-MED II PTV CATHETERS
K030589 · NuMED, Inc. · May 2003
5F MEDTRONIC LAUNCHER GUIDE CATHETER
K030779 · Medtronic Vascular · Apr 2003